Publications & Works

Publication Network
Articles 20
All (20)
SCI-E, SSCI, AHCI (9)
SCI-E, SSCI, AHCI, ESCI (10)
ESCI (1)
Scopus (11)
TRDizin (6)
Other Publications (3)

1. Comparative in vitro assessment of zirconia, lithium disilicate, and advanced lithium disilicate ceramics for Ti-base restorations: Surface roughness, cytocompatibility, and quantitative fibroblast adhesion response

Altıok D., Coşar B., Sancar E., Kılıç P., Erkut S.
The Journal of Prosthetic Dentistry , vol.0, no.0, 2026 (Peer-Reviewed Journal)

2. The intersection of CAR-T immunotherapy with emerging technologies

Coşar B., Kılıç P., İşeri Ö. D.
Cytokine and Growth Factor Reviews , vol.86, pp.238-259, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Residual protein analysis by SDS-PAGE in clinically manufactured BM-MSC products

Kılıç P., Karabudak S., Cosar B., Savran B. N., Yalcin M.
ELECTROPHORESIS , vol.45, no.17-18, pp.1606-1617, 2024 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

4. A review of pediocins and pediocin-like bacteriocins (PLBs)

Minaz Y. A., Karagulleoglu Z. Y., Nehri L. N., Tekeli C., Oney T. M., KILIÇ P., et al.
LATIN AMERICAN APPLIED RESEARCH , vol.54, no.1, pp.107-118, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

5. It isn't over ‘till it’s over: A continuing concern of the SARS-CoV-2 variants, and miRNAs targeting the S protein as a probable absolute cure

Kilic P., Cosar B., Ince A. T., Cebbaroglu D. D., Tekeli C., Benli E., et al.
Experimental Biomedical Research , pp.57-76, 2023 (TRDizin)

6. SARS-CoV-2 Mutations and their Viral Variants

Cosar B., Karagulleoglu Z. Y., Unal S., Ince A. T., Uncuoglu D. B., Tuncer G., et al.
CYTOKINE & GROWTH FACTOR REVIEWS , vol.63, pp.10-22, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

7. Host variations in SARS-CoV-2 infection

Altiok D., Savci E. Z., Ozkara B., Alkan K., Namdar D. S., Tuncer G., et al.
TURKISH JOURNAL OF BIOLOGY , vol.45, no.4, pp.404-424, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

8. Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

Kılıç P., Bay M., Baydın P., Şeker Ş., Coşkun Ö., Ülker O. L., et al.
Experimental Biomedical Research , vol.3, no.4, pp.231-238, 2020 (TRDizin) Creative Commons License identifier

9. Understanding factors affecting human chondrocyte culturing: an experimental study

Kilic P., Gurcan C., Gurman G., Yılmazer Aktuna A.
CELL AND TISSUE BANKING , vol.4, no.21, pp.585-596, 2020 (SCI-Expanded, Scopus)

10. Stem Cells and Psyche: Perspectives and a Review of the Literature

Kumbasar H., Duman B., Kurt Yüksel M., Civriz Bozdağ S., Kılıç P., Yılmazer Aktuna A., et al.
Journal of oncological sciences , vol.6, no.2, pp.103-118, 2020 (TRDizin)

11. Where is human-based cellular pharmaceutical R&D taking us in cartilage regeneration?

Alkaya D., Gurcan C., Kılıç P., Yılmazer Aktuna A., Gürman G.
3 BIOTECH , vol.10, no.4, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

12. A CD34+Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System

Kılıç P., Bay M., Yildirim Y., Coskun Ö., Seker Ş., Baydın P., et al.
CELLS TISSUES ORGANS , vol.207, no.1, pp.15-20, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

13. Cellular therapies: Day by day, all the way

Atilla E., Kılıç P., Gürman G.
TRANSFUSION AND APHERESIS SCIENCE , vol.57, no.2, pp.187-196, 2018 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

14. Imatinib and Norimatinib Plasma Levels Analyses of Chronic Myeloid Leukemia Patients

Kılıç P., Kayaaltı Z., Gündüz M., Gürman G., Söylemezoğlu T.
Literatür Eczacılık Bilimleri Dergisi , vol.5, no.2, 2016 (TRDizin)

15. An Overview of the Orphan Medicines Market in Turkey.

Koçkaya G., Wertheimer A. I., Kılıç P., Tanyeri P., Vural İ. M., Akbulat A., et al.
VALUE IN HEALTH REGIONAL ISSUES , vol.4, pp.47-52, 2014 (Scopus) identifier

16. Orphan drug regulations in Turkey

Kılıç P., Koçkaya G., Yemşen Ö., Tan C., Öztunca F. H., Aksungur P., et al.
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH , vol.3, no.4, pp.151-153, 2013 (Scopus)

17. Results of reference pricing and reimbursement discount rate schemes of Turkey

Koçkaya G., Atikeler K., Tuna E., Kılıç P., Tanyeri P., Umman N., et al.
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS , vol.14, no.2, pp.99-103, 2013 (ESCI)

18. Pharmaceutical Policies and Market Access in Turkey

Kılıç P., Koçkaya G.
ISPOR CONNECTIONS , no.18, pp.8-10, 2012 (Peer-Reviewed Journal)

19. Medical Device Policies Market Access in Turkey,

Koçkaya G., KILIÇ P., Güler I., Ünal A.
Ispor connectıons , 2012 (Peer-Reviewed Journal)

20. Türkiye Anjiotensin Reseptör Blokerleri ve Anjiotensin Dönüştürücü Enzim İnhibitörlerinin Yıllar İçerisinde Tüketim Bütçe ve Fiyat Değişim Analizi

Koçkaya G., Tanrıyeri P., KILIÇ P., Vural İ. M., Akbulat A., Artıran G., et al.
MN Kardiyoloji , 2012 (TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences 21

1. Optimizing culture to improve metabolic stability and proliferative capacity of bone marrow-derived mesenchymal stromal cells

Kılıç P., Özdemir Saka C., Coşar B., Savran B. N., Çetindağ E. N., Cengiz Seval G., et al.
23. Uluslararası Katılımlı Biyoteknoloji Kongresi, Ankara, Turkey, 23 - 25 October 2025, (Full Text)

2. Ensuring Quality and Consistency in Cellular Therapeutics: Analytical Insights From Residual Protein Assessment

Kılıç P.
4th International Conference on Chemistry and Chemical Engineering, Paris, France, 21 - 22 July 2025, (Summary Text)

3. An In Vitro Visit to Extracellular Vesicles as Screening Tools for Breast Cancer

Coşar B., Yaşar H. A., Erdemli Ö., Ürün Y., Gürman G., Darcansoy İşeri Ö., et al.
European Biotechnology Congress 2024, İstanbul, Turkey, 3 - 05 October 2024, (Summary Text)

4. The predicted biomarkers hsa-miR-1249-5p and hsa-miR-320b via the common target gene PROK2 in b-cell apoptosis in T1D

Kılıç P., Belder N., Coşar B., Savran B. N.
ISOPS 2024 , Ankara, Turkey, 25 - 28 June 2024, pp.0-2, (Summary Text)

5. PiggyBac (PB) Vector System-Mediated Reprogramming of Cells Designed with OCT4 and Lin28A/B Subgroups:A Discussion on The Expected Pluripotent Properties of The iPSC Yield

Kılıç P., Coşar B.
2. International Paris Congress on Medical and Health Sciences, Paris, France, 24 - 26 October 2023, pp.124-125, (Summary Text)

6. Hsa-mir-144-3p/hsa-mir-30d-5p: Could Common Dmxl2 Be a Biomarker Panel for Diabetes and Concomitant Neuropathy?

Kılıç P., Belder N., Coşar B., Oruç F.
22. Uluslararası Katılımlı Ulusal Biyoteknoloji Kongresi, Ankara, Turkey, 20 - 22 October 2023, (Summary Text)

7. Identification and Investigation of GLUT4-Associated miRNAs and Their Target Genes Potentially Responsible for Tissue Damage in Diabetes Mellitus

Kılıç P., Coşar B.
BIO Türkiye-Uluslararası Biyoteknoloji Kongresi, İstanbul, Turkey, 28 - 30 September 2023, pp.83-84, (Summary Text)

8. ‘Sensitive’ Brain Studies: Ethical Discussions

Kılıç P., Turhan N.
Uluslararası Sağlık Araştırmaları Kongresi 2022, Ankara, Turkey, 8 - 09 December 2022, (Summary Text)

9. Mononuclear Cell Distribution Analysis in Peripheral Blood as regards Individual Discrepancies

Kılıç P., Ipek Ş., Coşar B., Yalçın M., Savran B. N., Korkmaz F. N., et al.
Uluslararası Sağlık Araştırmaları Kongresi 2022, Ankara, Turkey, 8 - 09 December 2022, (Summary Text)

10. The Path from PBMC to iPSC: Determining the Effect of Transposon Concentration and Culture Conditions on Transfection Efficiency

Coşar B., Barokah A. N., Dönmez M. H., Korkmaz Bayram K., Kılıç P.
Uluslararası Kapadokya Sağlık ve Yaşam Kongresi, Nevşehir, Turkey, 24 - 26 August 2022, pp.169-185, (Full Text)

11. Comparison of Trypsin and Trypsin Inhibitor Concentrations by SDS-PAGE in Clinically Manufactured Mesenchymal Stem Cell Products

Karabudak S., Coşar B., Kılıç P.
Uluslararası Kapadokya Sağlık ve Yaşam Kongresi 2022 (UKSAY-2022), Nevşehir, Turkey, 24 August 2022, pp.60-61, (Summary Text)

12. Comparison of Orthologous TCF7L2 and pan Genes in terms of Insulin Signaling Pathway with Bioinformatics Approaches

Coşar B., Kılıç P., Kandemir B., Darcansoy İşeri Ö.
21. Uluslararası Katılımlı Biyoteknoloji Kongresi, Ankara, Turkey, 27 - 28 December 2021, (Summary Text)

13. Optimizing the Isolation and Culturing Conditions of Human Autologous Chondrocytes

Kılıç P., Gürcan C., Alkaya D., Gürman G., Yılmazer Aktuna A., Malatyalı B., et al.
BIOMED2019, İzmir, Turkey, 27 - 30 October 2019, (Summary Text)

14. An Overview to Imatinib Efficacy and Resistance Mechanisms

Kılıç P.
2nd International Congress on Forensic Toxicology: Industrial and Environmental Toxicology, Ankara, Turkey, 26 - 30 May 2016, (Summary Text)

15. Imatinib Monitoring in Chronic Myeloid Leukemia Patients

Kılıç P., Gürman G., Kayaaltı Z., Söylemezoğlu T., Gündüz M.
51st Congress of the European Societies of Toxicology, Porto, Portugal, 13 - 16 September 2015, (Summary Text)

16. Plasma Concentrations of Imatinib and N-Desmethyl Imatinib in Chronic Myeloid Leukemia Patients

Kılıç P., Kayaaltı Z., Gündüz M., Gürman G., Söylemezoğlu T.
1st International Congress on Forensic Toxicology Congress and Workshop of Forensic Toxicology, Ankara, Turkey, 29 - 30 November 2014, (Summary Text)

17. Reference Pricing Proposal Based on Gross Domestic Product per Capita

Kılıç P., Koçkaya G., Koçkaya P., Wertheimer A.
ISPOR, Michigan, United States Of America, 03 April 2012, (Summary Text)

18. Orphan Medicine Expenditures in Turkey

KILIÇ P., KOÇKAYA G., TANYERİ P., VURAL E. H., Durmuş N., VURAL İ. M., et al.
6th Eastern Conference for Rare Diseases and Orphan Drugs, 24 November 2011

19. General Directorate of Pharmaceuticals and Pharmacy Current Policies on Advanced Medical Products

Kılıç P., Işıkdemir F., Turgut G., Öztunca H., Tanyeri P., Septioğlu A. S.
12.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 27 October 2011, (Summary Text)

20. The Regulatory Process for Orphan Medicinal Products in Turkey

KILIÇ P., KERMAN S., AKSUNGUR AYDIN P., Yemşen Ö., TAN C., Öztunca H.
6th Eastern Conference for Rare Diseases and Orphan Drugs, 24 October 2011

21. The investigation of Antinociceptive Activity of Memantine with p-benzoquinone Writhing Test in Day and Night Rhythm

KILIÇ P., AYPAR E., Turan N., Abacığoğlu N.
ISOPS International Symposium on Pharmaceuticals Sciences, 13 June 2006
Books 4

1. Upstream Process Protocol for MSCs Isolated from Different Human-Based Tissue Origins

Kılıç P., Özdemir Saka C., Coşar B., Savran B. N., Sarıkaya A., Sargon B., et al.
in: Methods in Molecular Biology, John M. Walker, Editor, Springer Nature, New York, pp.1-15, 2024

2. An Optimized Protocol for piggyBac-Induced iPSC Generation from PBMCs by Automatic Electroporation

Kılıç P., Coşar B.
in: Stem Cells and Lineage Commitment Methods in Molecular Biology, Kürşad Türksen, Editor, Humana Press, Inc. , New York, pp.193-205, 2023

3. Quality management systems (QMSs) of human-based tissue and cell manufacturing facilities

Kılıç P.
in: Stem cells and good manufacturing practices, Kursad Turksen, Editor, Humana Press, Inc. , New York, pp.263-279, 2021

4. COVID-19 ve Hücresel Tedaviler

Cengiz Seval G., Kılıç P., Gürman G.
in: COVID-19 Özel: Hematoloji ve COVID-19 , Osman İlhan,Selami Koçak Toprak, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.65-69, 2020
Metrics

Publication

45

Publication (WoS)

10

Publication (Scopus)

11

Citation (WoS)

138

H-Index (WoS)

5

Citation (Scopus)

148

H-Index (Scopus)

5

Citation (Scholar)

311

H-Index (Scholar)

6

Citation (Sobiad)

16

H-Index (Sobiad)

2

Total Citation Count

613

Project

9

Intellectual Property

1

Thesis Advisory

2

Open Access

2
UN Sustainable Development Goals